OIRA Conclusion of EO 12866 Regulatory Review

RIN: 0910-ZB93         View EO 12866 Meetings	Received Date: 02/28/2024
Title: Select Updates for the Premarket Cybersecurity Guidance: Section 524B of the Federal Food, Drug, and Cosmetic Act; Draft Guidance for Industry and Food and Drug Administration Staff; Availability
Agency/Subagency: HHS / FDA	Stage: Notice
Concluded Action: Consistent without Change	Concluded Date: 03/07/2024
Legal Deadline: None	Economically Significant: No
Publication Date:	Unfunded Mandates: No
Major: No	Related To Homeland Security: No
Regulatory Flexibility Analysis Required: No	Small Entities Affected:
Federalism Implications: No	Affordable Care Act [Pub. L. 111-148 & 111-152]: No
International Impacts: No	Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]: No
Pandemic Response: No